General
| Peptide: | LL-37 |
| Microorganism: | Staphylococcus aureus |
| Administration: | |
| Stage: | Preformed biofilm |
| Notes: | S. aureus strain LUH14616 |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Total countable CFUs | 21 - 50% | 12.5 uM | |
| Total countable CFUs | 21 - 50% | 25 uM | |
| Total countable CFUs | 51 - 90% | 50 uM |
Reference
- E. M. Haisma, A. de Breij, H. Chan, J. T. van Dissel, J. W. Drijfhout, P. S. Hiemstra, A. El Ghalbzouri, P. H. Nibbering LL-37-Derived Peptides Eradicate Multidrug-Resistant Staphylococcus aureus from Thermally Wounded Human Skin Equivalents
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com